Spherix finds that perceptions related to efficacy appear to be impacting the new, more convenient formulation of the α4β7 integrin...
After several months on the market to treat lupus nephritis, uptake and prescribing patterns of Benlysta and Lupkynis reveal nephrologists...
Neurologists in Canada are receptive to having a fourth S1P receptor modulator option in Janssen’s Ponvory, although increasing the clinical...
According to new research from Spherix Global Insights, the FDA approval of Farxiga is likely to ignite a shift towards...
New research from Spherix Global Insights finds the impressive uptake of AbbVie’s Ubrelvy and Biohaven’s Nurtec ODT appears to have...
Aside from an in-depth evaluation of the current diagnosis and management of NAFLD/NASH, ten pipeline product profiles were evaluated by...
US dermatologists report increased confidence in treating psoriatic arthritis patients without a rheumatologist, and the two specialist groups report different...
Findings from the 16th wave of Spherix Global Insights’ COVID-19 research indicate that telemedicine is firmly entrenched, industry interaction remains...
While early patterns suggest that Genentech’s Ocrevus largely evades newcomer Novartis’ Kesimpta, COVID-19-related shifts in prescribing may be the real...
Six pipeline product profiles were evaluated by current inflammatory bowel disease treaters to assess strengths, weaknesses, and potential prescribing levels...
Spherix announces the release of three new research publications in its RealWorld Dynamix™ series, revealing patient types, treatment paradigms, and...
According to Spherix Global Insights, nephrologists and rheumatologists express measured optimism about these treatment options and seek more experience with...
